Summit Therapeutics Inc. (SMMT) Net income 2017–2025
Summit Therapeutics Inc. (SMMT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.1BFY2025 · since FY2017: -$26.4M → -$1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.1B | -387.8% |
| FY2024 | -$221.3M | +64.0% |
| FY2023 | -$614.9M | -680.5% |
| FY2022 | -$78.8M | +11.1% |
| FY2021 | -$88.6M | -68.1% |
| FY2020 | -$52.7M | — |
| FY2018 | $10.9M | +141.2% |
| FY2017 | -$26.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMMT financial trends
SMMT RevenueSMMT Net marginSMMT Gross profitSMMT Gross marginSMMT Operating incomeSMMT Operating marginSMMT Operating cash flowSMMT Free cash flowSMMT Capital expendituresSMMT Return on equitySMMT Stock buybacksSMMT Dividends paidSMMT Total assetsSMMT Total liabilitiesSMMT Shareholders’ equitySMMT overview →